Pliant Therapeutics (PLRX)

• Market cap: $111M
• 1 day: -3.21%
• 5 days: 14.56%
• 1 month: 20.67%
• 3 months: 15.29%
• 6 months: 20.67%
• Year to date: -86.37%
• 1 year: -87.63%
• 5 years: -92.15%
• 10 years: -91.5%
• Sector: Healthcare
• Industry: Biotechnology

About: Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Employees: 171